New Leader, New Directions for Shareable Ink
There has been a lot of change for patient documentation software vendor Shareable Ink during the past year.
There has been a lot of change for patient documentation software vendor Shareable Ink during the past year.
The company historically has sold a documentation system that uses specialized paper and pens that enable clinicians to write on printed forms and have the writing captured and converted to electronic data. More than half of clients still use this technology, but increasing numbers of new and existing customers are opting for an iPad version that came out during 2013 and has become the preferred way to document, says Laurie McGraw, president and CEO.
McGraw came to Shareable Ink in June 2013, succeeding co-founder Stephen Hau who started the company in 2009 and now serves as chief technology officer. Hau also founded PatientKeeper in 1996. McGraw, a 20-year health information technology veteran with 13 years at Allscripts ending as chief client officer, started moving Shareable Ink to better take advantage of the electronic health records meaningful use program.
The iPad documentation product has a co-pilot decision support feature that gives suggestions to clinicians as they are writing notes, such as pointing out words that cannot be read or explaining that most colleagues in the organization are documenting the condition or visit in a specific manner. Use of the co-pilot can support improved quality and consistency of documentation at the point of data entry, which down the road can ease using the data to support meaningful use objectives. McGraw notes that documentation requirements under Stage 2 increase considerably compared with Stage 1.
Shareable Ink over the years also offered basic data analytics through canned operational and quality reports. With improved data consistency through the iPads, the company now can offer deeper analysis of collected data elements, such as such as tracking the percentage of patients being kept warm after coming out of surgery.
The vendor also has newer partnerships with Allscripts and Greenway Medical Technologies, which offer Shareable Inks documentation technology integrated with their electronic health records systems. Physicians who dislike documenting in the EHR can do it by handwriting on the iPad and have the data sent to the EHR.
Another new initiative is the Patient Intake Starter Kit to capture patient demographic and medical history information at registration, via the specialized pen/paper or an iPad, to capture data elements supporting Stages 1 and 2 objectives.
In 2013, 99.7 percent of the vendors physicians that attested under Stage 1 did so successfully, and the iPad and patient intake products can ease the task for Stage 2, McGraw says. Meaningful Use Stage 2 is just a whole lot of data that needs to be collected discreetly.
The company historically has sold a documentation system that uses specialized paper and pens that enable clinicians to write on printed forms and have the writing captured and converted to electronic data. More than half of clients still use this technology, but increasing numbers of new and existing customers are opting for an iPad version that came out during 2013 and has become the preferred way to document, says Laurie McGraw, president and CEO.
McGraw came to Shareable Ink in June 2013, succeeding co-founder Stephen Hau who started the company in 2009 and now serves as chief technology officer. Hau also founded PatientKeeper in 1996. McGraw, a 20-year health information technology veteran with 13 years at Allscripts ending as chief client officer, started moving Shareable Ink to better take advantage of the electronic health records meaningful use program.
The iPad documentation product has a co-pilot decision support feature that gives suggestions to clinicians as they are writing notes, such as pointing out words that cannot be read or explaining that most colleagues in the organization are documenting the condition or visit in a specific manner. Use of the co-pilot can support improved quality and consistency of documentation at the point of data entry, which down the road can ease using the data to support meaningful use objectives. McGraw notes that documentation requirements under Stage 2 increase considerably compared with Stage 1.
Shareable Ink over the years also offered basic data analytics through canned operational and quality reports. With improved data consistency through the iPads, the company now can offer deeper analysis of collected data elements, such as such as tracking the percentage of patients being kept warm after coming out of surgery.
The vendor also has newer partnerships with Allscripts and Greenway Medical Technologies, which offer Shareable Inks documentation technology integrated with their electronic health records systems. Physicians who dislike documenting in the EHR can do it by handwriting on the iPad and have the data sent to the EHR.
Another new initiative is the Patient Intake Starter Kit to capture patient demographic and medical history information at registration, via the specialized pen/paper or an iPad, to capture data elements supporting Stages 1 and 2 objectives.
In 2013, 99.7 percent of the vendors physicians that attested under Stage 1 did so successfully, and the iPad and patient intake products can ease the task for Stage 2, McGraw says. Meaningful Use Stage 2 is just a whole lot of data that needs to be collected discreetly.